1. Home
  2. NOTV vs BAFN Comparison

NOTV vs BAFN Comparison

Compare NOTV & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • BAFN
  • Stock Information
  • Founded
  • NOTV 1974
  • BAFN 1999
  • Country
  • NOTV United States
  • BAFN United States
  • Employees
  • NOTV N/A
  • BAFN N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • BAFN Savings Institutions
  • Sector
  • NOTV Health Care
  • BAFN Finance
  • Exchange
  • NOTV Nasdaq
  • BAFN Nasdaq
  • Market Cap
  • NOTV 62.5M
  • BAFN 65.2M
  • IPO Year
  • NOTV 1997
  • BAFN N/A
  • Fundamental
  • Price
  • NOTV $2.00
  • BAFN $14.60
  • Analyst Decision
  • NOTV Strong Buy
  • BAFN
  • Analyst Count
  • NOTV 1
  • BAFN 0
  • Target Price
  • NOTV $5.00
  • BAFN N/A
  • AVG Volume (30 Days)
  • NOTV 512.6K
  • BAFN 15.0K
  • Earning Date
  • NOTV 08-07-2025
  • BAFN 07-29-2025
  • Dividend Yield
  • NOTV N/A
  • BAFN 2.18%
  • EPS Growth
  • NOTV N/A
  • BAFN 116.26
  • EPS
  • NOTV N/A
  • BAFN 2.37
  • Revenue
  • NOTV $480,402,000.00
  • BAFN $80,167,000.00
  • Revenue This Year
  • NOTV $4.99
  • BAFN N/A
  • Revenue Next Year
  • NOTV $5.39
  • BAFN N/A
  • P/E Ratio
  • NOTV N/A
  • BAFN $6.21
  • Revenue Growth
  • NOTV N/A
  • BAFN 2.60
  • 52 Week Low
  • NOTV $1.15
  • BAFN $11.98
  • 52 Week High
  • NOTV $6.48
  • BAFN $19.75
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 49.04
  • BAFN 45.43
  • Support Level
  • NOTV $2.06
  • BAFN $14.26
  • Resistance Level
  • NOTV $2.30
  • BAFN $15.45
  • Average True Range (ATR)
  • NOTV 0.17
  • BAFN 0.55
  • MACD
  • NOTV 0.02
  • BAFN 0.06
  • Stochastic Oscillator
  • NOTV 70.31
  • BAFN 31.59

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About BAFN BayFirst Financial Corp.

BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.

Share on Social Networks: